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1. Introduction 
Purification of human a-Lfucosidase is essential 
for the further study of the genetic disorder of 
fucosidosis in which this enzyme is defective [ 11, and 
for any proposed attempts at enzyme replacement in 
these cases. The enzyme is also in demand from 
workers studying the role of fucose as an important 
terminal sugar in the complex carbohydrates of cell 
surfaces. Proteins capable of specific binding to such 
fucose residues have been isolated from plant 
materials [2] and we considered that the affinity 
methods used for their purification might also be 
applicable to the isolation of the hydrolase. 
A 20% w/v homogenate of human liver in 50 mM 
sodium acetate buffer, pH 5.0, containing 1 mM EDTA 
was centrifuged at 9000 rpm for 15 min in an M.S.E. 
18 refrigerated centrifuge and the supernatant pre- 
cipitated by 60% saturation with solid ammonium 
sulphate. This precipitate was collected by centrifu- 
gation and re-suspended in about one-tenth the 
original volume of 50 mM phosphate buffer, pH 6.8, 
and de-salted by passing through a column of 
Sephadex G-25 equilibrated with the same buffer. 
A final volume of about 100 ml of crude enzyme 
preparation was obtained from an initial 500 ml of 
liver homogenate with no appreciable loss of total 
activity. 
2. Experimental 
2.1. Materials 
Samples of the affinity ligand N(e-amino-caproyl)- 
/3-Lfucosylamine was kindly supplied by Miles-Yeda 
Ltd., Rehovoth, Israel. This ligand condensed onto 
Agarose is commercially available for purification of 
fucose-binding protein and was purchased from Miles 
Laboratories Ltd., Stoke Poges, Slough, England. 
LFucose was purchased (Sigma Chemical Corp., 
Missouri, USA), p-nitrophenyl ar-Lfucoside was 
synthesised by published methods [3], and 4-methyl- 
umbelliferyl a-Lfucoside was purchased from Koch- 
Light Laboratories, Colnbrook, Bucks. 
2.2. Enzyme preparation 
A 40% w/v homogenate of post-mortem human 
liver in 100 mM phosphate-citric acid buffer, pH 5.5, 
was used for inhibition studies. The starting material 
for affinity chromatography was prepared as follows: 
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2.3. Enzymk assay 
The enzyme solution (100 ~1) was added to 50 ~1 
of 10 mM p-nitrophenyl-cu-Lfucoside in 100 mM 
disodium hydrogen phosphate adjusted to pH 5.5 
with 100 mM citric acid and incubated for 30 min. 
at 37’C. The reaction was stopped by addition of 
3 ml of 0.2 M glycine-Naz CO3 buffer, pH 10.7, and 
the liberated p-nitrophenol measured spectrophoto- 
metrically by its absorbance at 400 nm. The results 
were compared with blank assays in which buffer had 
been substituted for the enzyme solution or substrate 
solution and the activity calculated as pmoles p-nitro- 
phenol liberated/min under these conditions. For 
inhibition studies at sub-optimal substrate concentrab 
tions 20 ~1 of 40% homogenate of human liver pre- 
pared as above were incubated with 40 ~1 of the 
above phosphate-citrate buffer, pH 5.5, containing the 
required concentration of substrate and 40 pl of the 
inhibitor solution in the same buffer. Incubations of 
1 hr at 37°C were followed by assay of liberated 
pnitrophenol as before. 
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2.4. Disc gel electrophoresis 
The protein patterns of starting material and most 
highly purified samples of a-Lfucosidase were 
examined by disc gel electrophoresis using standard 
methods and stained for protein with Coomassie Blue 
[4]. Enzyme activity was located by incubating the 
gels for 15 min at 37°C in 1 mM 4-methylumbelliferyl- 
o-Lfucoside in 100 mM phosphate-citrate buffer, 
pH 5.0, and viewing under UV light for the fluores- 
cence of liberated aglycone. 
2.5. Affinity chromatography 
A 5 ml column of Agarose-e-amino caproyl fucos- 
amine suspended in 50 mM sodium phosphate buffer, 
pH 6.8, was packed under gravity in a disposal syringe 
barrel and washed with several bed volumes of the 
same buffer. The enzyme sample (10 ml of above 
preparation) in this buffer was applied and elution 
continued at a flow rate of 16 ml/hr. After discarding 
the void volume (1.5 ml) fractions (4 ml) were collect- 
ed and monitored for a-Lfucosidase as described 
above and for protein by the absorbance at 280 nm. 
When this absorbance fell to a steady near-zero value 
the eluant was changed to 1% L-fucose in the same 
buffer (12 ml) and this was followed by 100 mM NaCl 
in the same buffer until no further protein could be 
detected in the eluate. The column was finally purged 
with 2 M NaCl in buffer (20 ml) before re-equilibrating 
in the original buffer (10 ml) ready for re-use. There 
appeared to be no appreciable loss in the binding 
capacity of the column for cr-Lfucosidase after 
several cycles of this procedure. Because of the 
inhibitory effect of fucose in the enzyme assay, the 
column samples were dialysed for 24 hr against 
6 changes of the phosphate buffer (pH 6.8) before 
assay. No significant change in volume was noted, and 
enzyme recovery was unaffected by this process. 
3. Results 
Both cr-L-fucose and the N(e-aminocaproyl)0-L 
fucosylamine behaved as competitive inhibitors for 
human liver cw-Lfucosidase, having Ki values of 
0.8 X 10m3 M and 2.6 X IO-” M respectively cal- 
culated from Lineweaver-Burk reciprocal plots. The 
apparent KM for p-nitrophenyl.ol-Lfucoside was 
1.1 X 10m3 M determined by the same method. 
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Fig. 1. Affinity chromatography of human liver cy-L-fucos- 
idase on Agarose-e-aminocaproyl-fucosamine. For details see 
text. Open circles, o-L-fucosidase activity expressed as 
pmoles pnitrophenol split/min/fraction. Closed circles 
absorbance at 280 nM. The 1% L-fucose solution was applied 
at fraction number 18 and 100 mM NaCl at fraction number 
24. 
There is thus a similar affinity for the proposed 
elutant and the ligand, despite the fact that the latter 
a b c 
Fig. 2. Disc polyacrylamide lectrophoresis of human liver 
aLfucosidase preparation in discontinuous Tris (pH 9.0)- 
Tris-glycine (pH 8.5) buffer using 8% gels: a) ammonium 
sulphate fraction of human liver; b) 1% fucose eluate from 
column; c) Enzyme activity located by Cmethylumbelliferyl 
a-Lfucoside. 
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has opposite anomeric configuration to the preferred 
substrate. The results of affinity chromatography are 
shown in fig. 1. In a typical experiment 90% of the 
cr-L-fucosidase applied to the column was eluted by 
1% fucose in buffer with an increase in specific 
activity of 250-fold. When 90 ml of the same enzyme 
preparation was applied in an attempt to saturate the 
column enzymic activity appeared in the main 
protein peak suggesting that saturation had taken 
place. After washing to a low protein level in the 
eluate and then applying the 1% fucose solution a 
total of 1.6 e.u. of activity (2.3 mg protein) were 
specifically eluted with a purification of 300-fold 
over the original preparation. Disc electrophoresis of 
the fucose-eluted product showed that it contained 
one major protein component, coinciding with the 
location of enzymic activity and traces of several 
minor constituents that were non-enzymic (fig. 2). 
4. Discussion 
A substantial degree of purification is obtained in 
one step on the affinity support described. In view 
of its original use for fucose-finding proteins it is not 
surprising that more than one protein species is eluted 
and these may include denatured a-fucosidase as well 
as other fucose-specific proteins with no hydrolytic 
activity. The question of anomeric specificity deserves 
mention. The ligand is stated to have &configuration 
and it is generally thought that glycosidases are 
absolutely specific for the stereochemistry of the 
glycosidic bond. Either this is not so in this case or 
the ligand contains a small proportion of the a-anomer. 
Blumberg [2] suggested a substitution of 2 pmoles of 
covalently bound fucosylamine/ml resin was obtain- 
able by the method used for preparation of the 
affinity support. If the lowest molecular weight form 
[5] of a-L-fucosidase (60 000) is assumed to have a 
single fucose-binding site the theoretical capacity of 
the column used should be approx. 600 mg protein. 
However, in practice many of the fucose substitutions 
may be inaccessible to the proteins and the working 
capacity of our column material was stated by the 
manufacturers to be 2.3 mg/ml for fucose-binding 
lectins with equivalent weight of 30 000. On this 
basis we might expect about 0.07 pmole of mono- 
valent enzyme bound/ml of resin or a total capacity 
of 23 mg. The observed capacity is only 10% of this 
and could be explained by the presence of some 
a-anomer in the original ligand. This problem may be 
resolved if the column saturated with a-L-fucosidase 
retains its normal capacity for fucose-binding lectins 
and vice versa. 
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